Get the Daily Brief
Latest Biotech News
FDA Reevaluates Drug Approval Processes and Regulatory Strategies
The FDA is scrutinizing its use of surrogate endpoints for expedited drug approvals, with CDER director George Tidmarsh indicating a 'close look' at these criteria to ensure clinical benefit....
Advances in Artificial Intelligence Revolutionize Biotech Research and Diagnostics
Artificial intelligence continues to transform biotechnology with several new innovations: Harvard Medical School researchers have developed an AI tool for real-time distinction between...
Promising Clinical Radiation Therapy Advances Across Multiple Cancer Types
Recent clinical trials demonstrate the efficacy and quality-of-life benefits of radiation therapies in cancer treatment. A decade-long study found stereotactic radiation matches surgery for...
Pioneering Immunotherapies and Cancer Research Reveal New Therapeutic Avenues
Breakthroughs in cancer immunotherapy show promise in addressing aggressive and treatment-resistant tumors. Researchers unveiled a biodegradable scaffold delivering TLR7/8 agonists that eradicated...
Major Funding and Investment Moves Signal Strategic Biotech Growth
Sanofi reinforced its commitment to biotechnology innovation with a $625 million capital boost to Sanofi Ventures, expanding total assets over $1.4 billion. The venture fund aims to back...
Innovations in Antibiotic Mechanisms Illuminate Bacterial Resistance Challenges
New research using high-resolution imaging reveals how polymyxin B, a last-resort antibiotic, kills bacteria by inducing energy-dependent disruption of the bacterial outer membrane. The study...
Cutting-Edge mRNA Vaccines Target Chronic and Infectious Diseases
Researchers have developed innovative mRNA vaccines expanding beyond infectious diseases. A novel intramuscular mRNA vaccine delivering LRG1 protein mRNA inhibited pathological neovascularization...
Healthcare Leadership Transitions and Market Responses in Pharma Sector
GlaxoSmithKline (GSK) announced CEO Emma Walmsley's departure effective December 31, transitioning leadership to Chief Commercial Officer Luke Miels on January 1. Walmsley’s nine-year tenure...
Breakthrough Single-Cell and Spatial Transcriptomics Tools Enhance Disease Research
Scientists at the University of California developed ClearSeqExtend, an advanced computational platform improving single-cell RNA sequencing analysis by correcting ambient RNA contamination and...
Genmab Acquires Merus for $8 Billion Boost in Head and Neck Cancer Drug
Genmab has announced an $8 billion all-cash acquisition of Dutch biotech Merus, securing full rights to Merus's late-stage bispecific antibody, petosemtamab, currently in pivotal trials for head...
Polymyxin B Antibiotic Discovered to Kill Bacteria via Energy-Dependent Membrane Disruption
Researchers from University College London and Imperial College London have elucidated the mechanism by which polymyxin B, a last-resort antibiotic against multidrug-resistant Gram-negative...
mRNA Vaccine Demonstrates Protection Against Macular Degeneration in Mouse Models
Scientists at the Institute of Science Tokyo have developed an intramuscularly delivered mRNA vaccine encoding LRG1 protein that inhibits pathological neovascularization in the retina, effectively...
AI-Enabled 3D Molecular Search Platform ROCS X Unlocks Trillions of Drug-Like Compounds
Cadence Molecular Sciences, collaborating with Treeline Biosciences, has launched ROCS X, an AI-enhanced virtual screening platform that conducts ultra-fast 3D searches on trillions of...
Advances in Radiation Therapy Show Parity and Patient Benefits in Cancer Treatments
Several landmark clinical trials have revealed significant findings in radiation oncology. A decade-long study demonstrated that stereotactic radiation matches surgery in long-term survival for...
Type V CRISPR Systems Emerged from Transposons via RNA Splitting Mechanism
A team led by Caixia Gao at the Chinese Academy of Sciences has uncovered the evolutionary origin of Type V CRISPR-Cas systems (Cas12 enzymes) revealing that functional RNA splitting events...
UniQure’s Gene Therapy Slows Huntington’s Disease Progression in Landmark Clinical Data
UniQure announced compelling 36-month clinical data from its AMT-130 gene therapy in Huntington’s disease showing a significant slowing of disease progression. High-dose patients achieved a 75%...
Nanoparticle-Enhanced Microelectrodes Advance Brain-Machine Interface Stability
A recent study has demonstrated that incorporating nanoparticles into intracortical microelectrodes significantly boosts their recording longevity and stability by attenuating the brain’s foreign...
Climb Bio’s CLYM116 Shows Promising Preclinical Profile for Treating IgA Nephropathy
Climb Bio presented new nonhuman primate data for CLYM116, a next-generation anti-APRIL monoclonal antibody designed for IgA nephropathy (IgAN). The preclinical study demonstrated a longer...
Innovative Anti-Cancer Research: Ligands Targeting Tumor Carbohydrates and Induced Mesenchymal Stem Cell Therapy
Researchers at University of California, Irvine have engineered lectin-based therapeutic proteins with a Velcro-like strong and highly specific binding to tumor-associated carbohydrate antigens....
Genmab Bolsters Pipeline: $8B Merus Buyout Targets Head and Neck Cancer
Genmab announced its acquisition of Dutch biotech Merus for approximately $8 billion in cash, securing rights to Merus’ bispecific antibody petosemtamab in late-stage development for head and neck...